Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption.
Sign Up to like & getrecommendations! Published in 2019 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2019.0063
Abstract: This medical record review investigates whether use of topical clindamycin and/or oral tetracyclines during management of epidermal growth factor receptor (EGFR) inhibitor–related papulopustular eruption is associated with antibiotic-resistant bacterial infection. read more here.
Keywords: related papulopustular; factor receptor; growth factor; papulopustular eruption ... See more keywords
Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.41720
Abstract: This randomized clinical trial of women with breast cancer assesses whether short-term acupuncture reduces long-term aromatase inhibitor–related joint pain compared with sham acupuncture or a waiting list control. read more here.
Keywords: joint pain; acupuncture; related joint; sham acupuncture ... See more keywords
Value of Onconeural Antibodies in Checkpoint Inhibitor‐Related Toxicities
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Neurology"
DOI: 10.1002/ana.25764
Abstract: Value of Onconeural Antibodies in Checkpoint Inhibitor-Related Toxicities Alberto Vogrig, MD , Sergio Muñiz-Castrillo, MD , and Jérôme Honnorat, MD, PhD An increasing number of patients will be exposed to immune checkpoint inhibitors (ICIs) in… read more here.
Keywords: related toxicities; onconeural antibodies; antibodies checkpoint; value onconeural ... See more keywords
Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management
Sign Up to like & getrecommendations! Published in 2020 at "Current Oncology Reports"
DOI: 10.1007/s11912-020-00931-w
Abstract: Purpose of Review Multiple myeloma is the second most common hematologic malignancy in the USA, with over 32,000 new cases and nearly 13,000 deaths expected in 2019. The past few decades in myeloma research have… read more here.
Keywords: proteasome inhibitor; related cardiotoxicity; cardiotoxicity mechanisms; cardiotoxicity ... See more keywords
A case of immune checkpoint inhibitor-related colitis with a distinctive endoscopic finding of colonic pseudolipomatosis
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Journal of Gastroenterology"
DOI: 10.1007/s12328-021-01459-7
Abstract: A man in his 70s received anticancer chemotherapy with the anti-programmed cell death protein–ligand 1 antibody atezolizumab for non-small cell lung cancer. Ten days later, he developed diarrhea and skin rash, which were suspected to… read more here.
Keywords: immune checkpoint; related colitis; checkpoint; colonic pseudolipomatosis ... See more keywords
Immune checkpoint inhibitor-related acral vasculitis
Sign Up to like & getrecommendations! Published in 2018 at "Journal for Immunotherapy of Cancer"
DOI: 10.1186/s40425-018-0443-6
Abstract: Commentary on « Ipilimumab induced vasculitis » by Padda A. et al., J Immunother Cancer. 2018;6:12. The authors diagnosed a small vessel vasculitis following treatment with anti-CTLA-4 (ipilimumab) for a resected stage III B/C melanoma.… read more here.
Keywords: immune checkpoint; vasculitis; acral vasculitis; related acral ... See more keywords
Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study
Sign Up to like & getrecommendations! Published in 2022 at "PLOS ONE"
DOI: 10.1371/journal.pone.0275865
Abstract: An increasing number of patients with cancer are being treated with immune checkpoint inhibitors. Consequently, the incidence of immune checkpoint inhibitor-related myocarditis has been increasing. Nonetheless, the diagnostic criteria for the immune checkpoint inhibitor-related myocarditis… read more here.
Keywords: checkpoint inhibitor; immune checkpoint; myocardial damage; checkpoint ... See more keywords
Comparative efficacy and safety of immune checkpoint inhibitor-related therapies for advanced melanoma: a Bayesian network analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.18906
Abstract: OBJECTIVES We aimed to compare and rank the effects of 9 immune checkpoint inhibitor-related therapies for treating advanced melanoma. METHODS We searched Pubmed, Cochrane databases, Web of Science, and ClinicalTrials.gov for randomized controlled trials of… read more here.
Keywords: immune checkpoint; advanced melanoma; ipilimumab plus; checkpoint inhibitor ... See more keywords
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Management and Research"
DOI: 10.2147/cmar.s136818
Abstract: Immune checkpoint inhibitors, including cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death-1 (PD-1) inhibitors, represent an effective treatment modality for multiple malignancies. Despite the exciting clinical benefits, checkpoint inhibition is associated with a series… read more here.
Keywords: management strategies; treatment; management; related pneumonitis ... See more keywords
Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2023.1112222
Abstract: Background Immune checkpoint inhibitor-related myocarditis is the deadliest complication of immunotherapy. However, the underlying pathophysiological mechanisms of its occurrence and development remain unclear. Due to the long-term lack of effective early diagnosis and treatment options,… read more here.
Keywords: inhibitor related; related myocarditis; checkpoint inhibitor; immune checkpoint ... See more keywords
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor–related pneumonitis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.935779
Abstract: Background Checkpoint inhibitor–related pneumonitis (CIP) is a lethal immune-related adverse event. However, the development process of CIP, which may provide insight into more effective management, has not been extensively examined. Methods We conducted a multicenter… read more here.
Keywords: checkpoint inhibitor; acute phase; related pneumonitis; phase ... See more keywords